• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 2-(2,3-difluorophenyl)-4-nitrobenzoic Acid (CAS No. 1262006-28-9)

2-(2,3-difluorophenyl)-4-nitrobenzoic acid is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential biological activities. With the CAS number 1262006-28-9, this compound represents a niche yet promising candidate for further exploration in drug discovery and material science. The presence of both fluorine substituents and a nitro group in its aromatic ring system imparts distinct electronic and steric characteristics, making it a valuable scaffold for medicinal chemists seeking to develop novel therapeutic agents.

The molecular structure of 2-(2,3-difluorophenyl)-4-nitrobenzoic acid consists of a benzoic acid core substituted with a nitro group at the 4-position and a 2,3-difluorophenyl moiety at the 2-position. This arrangement not only enhances the compound's lipophilicity but also introduces specific interactions with biological targets. The fluorine atoms, in particular, are known to modulate enzyme binding affinities and metabolic stability, which are critical factors in drug design. Recent studies have highlighted the role of such fluorinated aromatic compounds in enhancing the efficacy of small-molecule drugs against various diseases.

In the realm of pharmaceutical research, 2-(2,3-difluorophenyl)-4-nitrobenzoic acid has been investigated for its potential as an intermediate in synthesizing bioactive molecules. Its nitro group can be further functionalized through reduction or diazotization reactions, allowing for the creation of diverse derivatives with tailored pharmacological properties. For instance, researchers have explored its utility in developing inhibitors targeting enzymes involved in inflammatory pathways. The nitro group's redox-active nature makes it particularly interesting for designing prodrugs that can release active species under physiological conditions.

The fluorinated phenyl ring in 2-(2,3-difluorophenyl)-4-nitrobenzoic acid contributes to its interaction with biological systems by influencing both hydrophobicity and electronic distribution. Fluoroaromatics are widely recognized for their ability to improve pharmacokinetic profiles, including bioavailability and blood-brain barrier penetration. This feature has prompted investigations into its use as a component in drugs designed to treat neurological disorders. Additionally, the electron-withdrawing nature of the nitro group enhances the compound's reactivity, enabling it to participate in various chemical transformations that could lead to novel therapeutic applications.

Recent advancements in computational chemistry have further illuminated the potential of 2-(2,3-difluorophenyl)-4-nitrobenzoic acid as a lead compound. Molecular docking studies have demonstrated its binding affinity to several protein targets, including those implicated in cancer and infectious diseases. These virtual screening approaches have identified promising scaffolds for further optimization, emphasizing the compound's role as a building block in drug discovery pipelines. The integration of machine learning algorithms has also enabled rapid prediction of physicochemical properties, streamlining the process of designing derivatives with improved drug-like characteristics.

In material science, 2-(2,3-difluorophenyl)-4-nitrobenzoic acid has been explored for its potential applications in organic electronics. Its aromatic structure and electronic properties make it suitable for use in organic semiconductors and light-emitting diodes (OLEDs). Researchers have investigated its performance as a hole-transporting material or an electron-transporting agent, highlighting its versatility beyond pharmaceutical applications. The ability to fine-tune its properties through structural modifications offers exciting opportunities for developing next-generation electronic devices.

The synthesis of 2-(2,3-difluorophenyl)-4-nitrobenzoic acid presents both challenges and opportunities for chemists. Traditional synthetic routes often involve multi-step processes that require careful control of reaction conditions to achieve high yields and purity. However, recent innovations in catalytic methods have provided more efficient pathways for producing this compound on an industrial scale. For example, transition metal-catalyzed cross-coupling reactions have enabled direct functionalization of the aromatic ring system, reducing the number of synthetic steps and improving overall efficiency.

The environmental impact of producing and utilizing 2-(2,3-difluorophenyl)-4-nitrobenzoic acid is another critical consideration. As interest in sustainable chemistry grows, researchers are exploring greener synthetic methods that minimize waste and reduce energy consumption. Biocatalytic approaches using enzymes have shown promise in facilitating selective transformations without harsh reagents or solvents. These advancements align with global efforts to promote sustainable practices across all stages of chemical manufacturing.

Future research directions for 2-(2,3-difluorophenyl)-4-nitrobenzoic acid include exploring its role in photodynamic therapy (PDT) and other light-based medical treatments. The compound's ability to generate reactive oxygen species upon irradiation with light makes it a candidate for developing photosensitizer-based therapies. Additionally, studies are underway to investigate its potential as an antimicrobial agent, leveraging its structural features to disrupt bacterial cell walls or inhibit essential metabolic pathways.

In conclusion, 2-(2,3-difluorophenyl)-4-nitrobenzoic acid (CAS No. 1262006-28-9) is a multifaceted compound with significant potential across multiple domains of science and technology. Its unique structural features make it an attractive candidate for drug discovery、material science，and sustainable chemistry initiatives。As research continues，the full scope of its applications is expected to expand，offering new solutions to complex challenges faced by modern society。

• 103978-24-1(3-(2-fluoro-5-nitrophenyl)benzoic acid)
• 103978-33-2([1,1'-Biphenyl]-4-carboxylicacid, 2'-fluoro-5'-nitro-)
• 1261962-57-5(3-(3-Fluoro-2-methylphenyl)-5-nitrobenzoic acid)
• 1261970-42-6(2'-Fluoro-4'-methyl-5-nitro-[1,1'-biphenyl]-3-carboxylic acid)
• 1261893-20-2(2-(3-fluoro-4-methylphenyl)-4-nitrobenzoic Acid)
• 1261932-51-7(2-(2-fluoro-4-methylphenyl)-4-nitrobenzoic Acid)
• 1262005-74-2(2-(3-fluoro-2-methylphenyl)-4-nitrobenzoic Acid)
• 1261991-29-0(3-(2,5-Difluorophenyl)-5-nitrobenzoic acid)
• 1262005-73-1(2-(2-fluoro-5-methylphenyl)-4-nitrobenzoic Acid)
• 1261964-43-5(3-Fluoro-4-(3-nitrophenyl)benzoic acid)